Trump's Drug Tariffs: Europe's Stocks Unfazed?
Update: 2025-09-26
Description
Trump's tariff threat on patented drugs barely ruffled European markets! Despite an initial dip in healthcare shares, the Stoxx Europe 600 index rose. Experts suggest holding steady on pharma stocks, citing a lack of detail in Trump's plan and potential political backlash. Investors are largely focused on the upcoming U.S. inflation data, hinting it may be a good time to consider adding European stocks to your portfolio.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
